Evidence map›Paper›PMID 35523793›Full record

ArticleNature communications2022

Distinctive molecular features of regenerative stem cells in the damaged male germline.

Hue M La, Jinyue Liao, Julien M D Legrand, Fernando J Rossello, Ai-Leen Chan, Vijesh Vaghjiani, Jason E Cain, Antonella Papa, Tin Lap Lee, Robin M Hobbs

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Rewinding the clock: mechanisms of dedifferentiation.Current opinion in genetics & development · 2025
    Review
  11. Article
  12. Article
  13. The Biology and Regulation of Spermatogonial Stem Cells in the Niche.Advances in experimental medicine and biology · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Hue M LaCentre for Reproductive Health, Hudson Institute of Medical Research, Melbourne, VIC, 3168, Australia.ORCID 0000-0003-4549-7017
Jinyue LiaoDevelopmental and Regenerative Biology Program, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Julien M D LegrandCentre for Reproductive Health, Hudson Institute of Medical Research, Melbourne, VIC, 3168, Australia.ORCID 0000-0001-5577-5645
Fernando J RosselloAustralian Regenerative Medicine Institute, Monash University, Melbourne, VIC, 3800, Australia.
Ai-Leen ChanCentre for Reproductive Health, Hudson Institute of Medical Research, Melbourne, VIC, 3168, Australia.
Vijesh VaghjianiDepartment of Molecular and Translational Sciences, Monash University, Melbourne, VIC, 3800, Australia.
Jason E CainDepartment of Molecular and Translational Sciences, Monash University, Melbourne, VIC, 3800, Australia.ORCID 0000-0003-3987-5894
Antonella PapaCancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia.ORCID 0000-0001-8653-7121
Tin Lap LeeDevelopmental and Regenerative Biology Program, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. leetl@cuhk.edu.hk.ORCID 0000-0002-6654-0988
Robin M HobbsCentre for Reproductive Health, Hudson Institute of Medical Research, Melbourne, VIC, 3168, Australia. robin.hobbs@monash.edu.ORCID 0000-0002-3853-2614
Australian Regenerative Medicine Institute · AUChinese University of Hong Kong · HKHudson Institute of Medical Research · AUMonash University · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintenance of male fertility requires spermatogonial stem cells (SSCs) that self-renew and generate differentiating germ cells for production of spermatozoa. Germline cells are sensitive to genotoxic drugs and patients receiving chemotherapy can become infertile. SSCs surviving treatment mediate germline recovery but pathways driving SSC regenerative responses remain poorly understood. Using models of chemotherapy-induced germline damage and recovery, here we identify unique molecular features of regenerative SSCs and characterise changes in composition of the undifferentiated spermatogonial pool during germline recovery by single-cell analysis. Increased mitotic activity of SSCs mediating regeneration is accompanied by alterations in growth factor signalling including PI3K/AKT and mTORC1 pathways. While sustained mTORC1 signalling is detrimental for SSC maintenance, transient mTORC1 activation is critical for the regenerative response. Concerted inhibition of growth factor signalling disrupts core features of the regenerative state and limits germline recovery. We also demonstrate that the FOXM1 transcription factor is a target of growth factor signalling in undifferentiated spermatogonia and provide evidence for a role in regeneration. Our data confirm dynamic changes in SSC functional properties following damage and support an essential role for microenvironmental growth factors in promoting a regenerative state.

Indexed as

Phosphatidylinositol 3-KinasesSpermatogenesisCell DifferentiationHumansIntercellular Signaling Peptides and ProteinsMaleMechanistic Target of Rapamycin Complex 1SpermatogoniaStem CellsTestisIntercellular Signaling Peptides and ProteinsMechanistic Target of Rapamycin Complex 1Phosphatidylinositol 3-Kinases

Identifiers

PMID35523793
PMCPMC9076627
OpenAlexW4229020947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.